Literature DB >> 8673844

Impact of a mass vaccination campaign against a meningitis epidemic in a refugee camp.

E Haelterman1, M Boelaert, C Suetens, L Blok, M Henkens, M J Toole.   

Abstract

Serogroup A meningococcus epidemics occurred in refugee populations in Zaire in August 1994. The paper analyses the public health impact of a mass vaccination campaign implemented in a large refugee camp. We compared meningitis incidence rates from 2 similar camps. In Kibumba camp, vaccination was implemented early in the course of the epidemic whilst in the control camp (Katale), vaccination was delayed. At a threshold of 15 cases per 100 000 population per week an immunization campaign was implemented. Attack rates were 94 and 134 per 100,000 in Kibumba and Katale respectively over 2 months. In Kibumba, one week after crossing the threshold, 121,588 doses of vaccine were administered covering 76% of all refugees. Vaccination may have prevented 68 cases (30% of the expected cases). Despite its rapid institution and the high coverage achieved, the vaccination campaign had a limited impact on morbidity due to meningitis. In the early phase in refugee camps, the relative priorities of meningitis vaccination and case management need to be better defined.

Entities:  

Mesh:

Year:  1996        PMID: 8673844     DOI: 10.1046/j.1365-3156.1996.d01-49.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  6 in total

Review 1.  Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.

Authors:  Idris Mohammed; Garba Iliyasu; Abdulrazaq Garba Habib
Journal:  Pathog Glob Health       Date:  2017-01-12       Impact factor: 2.894

2.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

Review 3.  Meningococcal vaccines. Current status and future possibilities.

Authors:  H Peltola
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

4.  Mass gatherings: a review of the scope for meningococcal vaccination in the Indian context.

Authors:  Anand P Dubey; Rashna Dass Hazarika; Veronique Abitbol; Shafi Kolhapure; Someya Agrawal
Journal:  Hum Vaccin Immunother       Date:  2021-02-19       Impact factor: 3.452

5.  Delivering infectious disease interventions to women and children in conflict settings: a systematic reviefw.

Authors:  Sarah Meteke; Marianne Stefopulos; Daina Als; Michelle Gaffey; Mahdis Kamali; Fahad J Siddiqui; Mariella Munyuzangabo; Reena P Jain; Shailja Shah; Amruta Radhakrishnan; Anushka Ataullahjan; Zulfiqar A Bhutta
Journal:  BMJ Glob Health       Date:  2020-04

6.  Meningococcal infections among refugees and immigrants: silent threats of past, present and future.

Authors:  Ener Cagri Dinleyici; Ray Borrow
Journal:  Hum Vaccin Immunother       Date:  2020-04-29       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.